Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00467558
Other study ID # 0701M00804
Secondary ID
Status Completed
Phase Phase 2
First received April 27, 2007
Last updated April 18, 2012
Start date May 2007
Est. completion date June 2010

Study information

Verified date April 2012
Source University of Minnesota - Clinical and Translational Science Institute
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in compulsive sexual behavior. Twenty subjects with DSM-IV compulsive sexual behavior will receive 8 weeks of naltrexone or placebo. The hypothesis to be tested is that naltrexone will be effective in reducing the urges to act out sexually in patients with compulsive sexual behavior. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.


Description:

The proposed study will consist of 8 weeks of treatment with either naltrexone or placebo in 20 subjects with compulsive sexual behavior.


Recruitment information / eligibility

Status Completed
Enrollment 7
Est. completion date June 2010
Est. primary completion date June 2010
Accepts healthy volunteers No
Gender Both
Age group 21 Years to 75 Years
Eligibility Inclusion Criteria:

1. men and women age 21-75;

2. current diagnosis of compulsive sexual behavior

Exclusion Criteria:

1. unstable medical illness or clinically significant abnormalities on prestudy laboratory tests or physical examination;

2. history of seizures;

3. myocardial infarction within 6 months;

4. current pregnancy or lactation, or inadequate contraception in women of childbearing potential;

5. clinically significant suicidality;

6. current or recent (past 1 month) DSM-IV substance abuse or dependence;

7. illegal substance within 2 weeks of study initiation;

8. initiation of psychotherapy or behavior therapy from a mental health professional within 3 months prior to study baseline;

9. initiation of a psychotropic medication within 2 months prior to study inclusion;

10. previous treatment with naltrexone; and

11. treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Naltrexone
daily
Sugar pill
daily

Locations

Country Name City State
United States University of Minnesota Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
University of Minnesota - Clinical and Translational Science Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Yale Brown Obsessive Compulsive Scale Modified for Compulsive Sexual Behavior (YBOCS) The YBOCS is a reliable and valid, 10-item, clinician-administered scale that rates buying symptoms within the last seven days, on a severity scale from 0 to 4 for each item (total scores range from 0 to 40 with higher scores reflecting greater illness severity). Assessed at each visit (every two weeks) until participation in the study was done (Week 8) No
Secondary Clinical Global Impression Scale - Severity The CGI consists of two reliable and valid 7-item Likert scales used to assess severity in clinical symptoms. The scale ranges from 1 = "very much improved" to 7 = "very much worse." The CGI severity scale was used at each visit and ranges from 1 = "not ill at all" to 7 = "among the most extremely ill." Assessed at each visit (every two weeks) until participation in the study was done (Week 8) No
See also
  Status Clinical Trial Phase
Recruiting NCT06408545 - Acceptance and Commitment Therapy for Problematic Chemsex N/A
Not yet recruiting NCT06406296 - Effectiveness of ACT for Problematic Chemsex N/A
Enrolling by invitation NCT04634175 - Mind-body Intervention for Compulsive Sexual Behavior Disorder N/A
Completed NCT05572372 - Effects of an ACT-based Psychological Treatment in Patients With Hypersexuality N/A
Completed NCT02300051 - Intervention Study for Individuals With Compulsive Sexual Behavior N/A
Completed NCT03495414 - Neurobiological Underpinnings to Hypersexual Disorder